Netherlands-based ScreenPoint Medical is an AI technology company that develops Deep Learning and image analysis technology for the automated reading of mammograms. Announced that it has raised $28 Million (approx. €23.58M) in its Series C round of funding.
The round was led by New York-based global venture capital and private equity firm, Insight Partners. In addition, existing investors including ScreenPoint Medical’s founders, Siemens Healthineers, and Oost NL, also invested in this round. The Series C round also saw participation from the University Radiology Group (URG).
Company: ScreenPoint Medical
Round: Series C
Funding Month: July 2021
Lead Investor: New York-based global venture capital and Insight Partners
Additional Investors: ScreenPoint Medical’s founders, Siemens Healthineers, Oost NL and URG
Company Website: https://screenpoint-medical.com/
Software Category: deep learning Artificial Intelligence
About the Company: ScreenPoint Medical was founded in 2014 by Professor Nico Karssemeijer and Professor Sir Michael Brady, world leading experts in quantitative breast image analysis and computer aided detection.